Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors.

Neuro-oncology advances

Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, Dessens AB, Waslander R, van den Adel TPL, Pluijm SMF, Reddingius RE, Michiels E, van den Heuvel-Eibrink MM, Hartman A.
PMID: 34988449
Neurooncol Adv. 2021 Nov 03;3(1):vdab161. doi: 10.1093/noajnl/vdab161. eCollection 2021.

BACKGROUND: Pediatric brain tumor survivors (PBTS) experience disease- and treatment-related sequelae. We aimed to investigate the occurrence of participation limitations, impairments in functioning, fatigue, and the association between patient, tumor- and treatment-related factors and these outcomes.METHODS: Children (4-18 years)...

Cite
Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, et al. Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neurooncol Adv. 2021;3(1):vdab161doi: 10.1093/noajnl/vdab161.
Verwaaijen, E. J., Catsman-Berrevoets, C. E., Maurice-Stam, H., Dessens, A. B., Waslander, R., van den Adel, T. P. L., Pluijm, S. M. F., Reddingius, R. E., Michiels, E., van den Heuvel-Eibrink, M. M., & Hartman, A. (2021). Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neuro-oncology advances, 3(1), vdab161. https://doi.org/10.1093/noajnl/vdab161
Verwaaijen, Emma J, et al. "Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors." Neuro-oncology advances vol. 3,1 (2021): vdab161. doi: https://doi.org/10.1093/noajnl/vdab161
Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, Dessens AB, Waslander R, van den Adel TPL, Pluijm SMF, Reddingius RE, Michiels E, van den Heuvel-Eibrink MM, Hartman A. Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neurooncol Adv. 2021 Nov 03;3(1):vdab161. doi: 10.1093/noajnl/vdab161. eCollection 2021. PMID: 34988449; PMCID: PMC8704380.
Copy Download .nbib Format: NLM
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.

Data in brief

Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O.
PMID: 32939381
Data Brief. 2020 Aug 24;32:106227. doi: 10.1016/j.dib.2020.106227. eCollection 2020 Oct.

Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (

Cite
Langer T, Clemens E, Broer L, et al. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020;32:106227doi: 10.1016/j.dib.2020.106227.
Langer, T., Clemens, E., Broer, L., Maier, L., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Pluijm, S. F. M., Binder, H., Mayer, B., von dem Knesebeck, A., Byrne, J., van Dulmen-den Broeder, E., Crocco, M., Grabow, D., Kaatsch, P., Kaiser, M., Spix, C., Kenborg, L., Winther, J. F., Rechnitzer, C., Hasle, H., Kepak, T., van der Kooi, A. F., Kremer, L. C., Kruseova, J., Bielack, S., Sorg, B., Hecker-Nolting, S., Kuehni, C. E., Ansari, M., Kompis, M., van der Pal, H. J., Parfitt, R., Deuster, D., Matulat, P., Tillmanns, A., Tissing, W. J. E., Beck, J. D., Elsner, S., Am Zehnhoff-Dinnesen, A., van den Heuvel-Eibrink, M. M., Zolk, O. (2020). Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief, 32106227. https://doi.org/10.1016/j.dib.2020.106227
Langer, Thorsten, et al. "Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset." Data in brief vol. 32 (2020): 106227. doi: https://doi.org/10.1016/j.dib.2020.106227
Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal HJ, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O. Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data Brief. 2020 Aug 24;32:106227. doi: 10.1016/j.dib.2020.106227. eCollection 2020 Oct. PMID: 32939381; PMCID: PMC7477761.
Copy Download .nbib Format: NLM
The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers.

European journal of cancer (Oxford, England : 1990)

van Kalsbeek RJ, van der Pal HJH, Hjorth L, Winther JF, Michel G, Haupt R, Uyttebroeck A, O'Brien K, Kepakova K, Follin C, Muraca M, Kepak T, Araujo-Soares V, Bardi E, Blondeel A, Bouwman E, Brown MC, Frederiksen LE, Essiaf S, Hermens RPMG, Kienesberger A, Korevaar JC, Mader L, Mangelschots M, Mulder RL, van den Oever S, Rijken M, Roser K, Skinner R, Pluijm SMF, Loonen JJ, Kremer LCM.
PMID: 34153717
Eur J Cancer. 2021 Aug;153:74-85. doi: 10.1016/j.ejca.2021.05.030. Epub 2021 Jun 18.

BACKGROUND: The majority of childhood cancer survivors are at risk of treatment-related adverse health outcomes. Survivorship care to mitigate these late effects is endorsed, but it is not available for many adult survivors of childhood cancer in Europe. The...

Cite
van Kalsbeek RJ, van der Pal HJH, Hjorth L, et al. The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers. Eur J Cancer. 2021;153:74-85doi: 10.1016/j.ejca.2021.05.030.
van Kalsbeek, R. J., van der Pal, H. J. H., Hjorth, L., Winther, J. F., Michel, G., Haupt, R., Uyttebroeck, A., O'Brien, K., Kepakova, K., Follin, C., Muraca, M., Kepak, T., Araujo-Soares, V., Bardi, E., Blondeel, A., Bouwman, E., Brown, M. C., Frederiksen, L. E., Essiaf, S., Hermens, R. P. M. G., Kienesberger, A., Korevaar, J. C., Mader, L., Mangelschots, M., Mulder, R. L., van den Oever, S., Rijken, M., Roser, K., Skinner, R., Pluijm, S. M. F., Loonen, J. J., Kremer, L. C. M. (2021). The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers. European journal of cancer (Oxford, England : 1990), 15374-85. https://doi.org/10.1016/j.ejca.2021.05.030
van Kalsbeek, Rebecca J, et al. "The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers." European journal of cancer (Oxford, England : 1990) vol. 153 (2021): 74-85. doi: https://doi.org/10.1016/j.ejca.2021.05.030
van Kalsbeek RJ, van der Pal HJH, Hjorth L, Winther JF, Michel G, Haupt R, Uyttebroeck A, O'Brien K, Kepakova K, Follin C, Muraca M, Kepak T, Araujo-Soares V, Bardi E, Blondeel A, Bouwman E, Brown MC, Frederiksen LE, Essiaf S, Hermens RPMG, Kienesberger A, Korevaar JC, Mader L, Mangelschots M, Mulder RL, van den Oever S, Rijken M, Roser K, Skinner R, Pluijm SMF, Loonen JJ, Kremer LCM. The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers. Eur J Cancer. 2021 Aug;153:74-85. doi: 10.1016/j.ejca.2021.05.030. Epub 2021 Jun 18. PMID: 34153717.
Copy Download .nbib Format: NLM
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Verwaaijen EJ, Ma J, de Groot-Kruseman HA, Pieters R, van der Sluis IM, van Atteveld JE, Halton J, Fernandez CV, Hartman A, de Jonge R, Lequin MH, Te Winkel ML, Alos N, Atkinson SA, Barr R, Grant RM, Hay J, Huber AM, Ho J, Jaremko J, Koujok K, Lang B, Matzinger MA, Shenouda N, Rauch F, Rodd C, van den Heuvel-Eibrink MM, Pluijm SMF, Ward LM.
PMID: 34610647
J Bone Miner Res. 2021 Dec;36(12):2290-2299. doi: 10.1002/jbmr.4442. Epub 2021 Oct 05.

Although bone fragility may already be present at diagnosis of pediatric acute lymphoblastic leukemia (ALL), routine performance of dual-energy X-ray absorptiometry (DXA) in every child is not universally feasible. The aim of this study was to develop and validate...

Cite
Verwaaijen EJ, Ma J, de Groot-Kruseman HA, et al. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. J Bone Miner Res. 2021;36(12):2290-2299doi: 10.1002/jbmr.4442.
Verwaaijen, E. J., Ma, J., de Groot-Kruseman, H. A., Pieters, R., van der Sluis, I. M., van Atteveld, J. E., Halton, J., Fernandez, C. V., Hartman, A., de Jonge, R., Lequin, M. H., Te Winkel, M. L., Alos, N., Atkinson, S. A., Barr, R., Grant, R. M., Hay, J., Huber, A. M., Ho, J., Jaremko, J., Koujok, K., Lang, B., Matzinger, M. A., Shenouda, N., Rauch, F., Rodd, C., van den Heuvel-Eibrink, M. M., Pluijm, S. M. F., Ward, L. M. (2021). A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(12), 2290-2299. https://doi.org/10.1002/jbmr.4442
Verwaaijen, Emma J, et al. "A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia." Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 36,12 (2021): 2290-2299. doi: https://doi.org/10.1002/jbmr.4442
Verwaaijen EJ, Ma J, de Groot-Kruseman HA, Pieters R, van der Sluis IM, van Atteveld JE, Halton J, Fernandez CV, Hartman A, de Jonge R, Lequin MH, Te Winkel ML, Alos N, Atkinson SA, Barr R, Grant RM, Hay J, Huber AM, Ho J, Jaremko J, Koujok K, Lang B, Matzinger MA, Shenouda N, Rauch F, Rodd C, van den Heuvel-Eibrink MM, Pluijm SMF, Ward LM. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. J Bone Miner Res. 2021 Dec;36(12):2290-2299. doi: 10.1002/jbmr.4442. Epub 2021 Oct 05. PMID: 34610647.
Copy Download .nbib Format: NLM
Self-rated health among older adults: a cross-national comparison.

European journal of ageing

Bardage C, Pluijm SMF, Pedersen NL, Deeg DJH, Jylhä M, Noale M, Blumstein T, Otero Á.
PMID: 28794727
Eur J Ageing. 2005 Jun;2(2):149-158. doi: 10.1007/s10433-005-0032-7. Epub 2005 May 14.

Self-rated health (SRH) may have different implications in various social and cultural settings. However, few studies are available concerning SRH among older persons across countries. The aim of this study was to analyse whether there are cross-national differences in...

Cite
Bardage C, Pluijm SMF, Pedersen NL, et al. Self-rated health among older adults: a cross-national comparison. Eur J Ageing. 2005;2(2):149-158doi: 10.1007/s10433-005-0032-7.
Bardage, C., Pluijm, S. M. F., Pedersen, N. L., Deeg, D. J. H., Jylhä, M., Noale, M., Blumstein, T., & Otero, �. �. (2005). Self-rated health among older adults: a cross-national comparison. European journal of ageing, 2(2), 149-158. https://doi.org/10.1007/s10433-005-0032-7
Bardage, Carola, et al. "Self-rated health among older adults: a cross-national comparison." European journal of ageing vol. 2,2 (2005): 149-158. doi: https://doi.org/10.1007/s10433-005-0032-7
Bardage C, Pluijm SMF, Pedersen NL, Deeg DJH, Jylhä M, Noale M, Blumstein T, Otero Á. Self-rated health among older adults: a cross-national comparison. Eur J Ageing. 2005 Jun;2(2):149-158. doi: 10.1007/s10433-005-0032-7. Epub 2005 May 14. PMID: 28794727; PMCID: PMC5547684.
Copy Download .nbib Format: NLM
Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: .

JACC. CardioOncology

Leerink JM, de Baat EC, Feijen EAM, Bellersen L, van Dalen EC, Grotenhuis HB, Kapusta L, Kok WEM, Loonen J, van der Pal HJH, Pluijm SMF, Teske AJ, Mavinkurve-Groothuis AMC, Merkx R, Kremer LCM.
PMID: 34396245
JACC CardioOncol. 2020 Sep 15;2(3):363-378. doi: 10.1016/j.jaccao.2020.08.006. eCollection 2020 Sep.

Cardiac diseases in the growing population of childhood cancer survivors are of major concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy continues to be relevant in the modern treatment era. Mitoxantrone has emerged as an important treatment-related...

Cite
Leerink JM, de Baat EC, Feijen EAM, et al. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: . JACC CardioOncol. 2020;2(3):363-378doi: 10.1016/j.jaccao.2020.08.006.
Leerink, J. M., de Baat, E. C., Feijen, E. A. M., Bellersen, L., van Dalen, E. C., Grotenhuis, H. B., Kapusta, L., Kok, W. E. M., Loonen, J., van der Pal, H. J. H., Pluijm, S. M. F., Teske, A. J., Mavinkurve-Groothuis, A. M. C., Merkx, R., & Kremer, L. C. M. (2020). Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: . JACC. CardioOncology, 2(3), 363-378. https://doi.org/10.1016/j.jaccao.2020.08.006
Leerink, Jan M, et al. "Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: ." JACC. CardioOncology vol. 2,3 (2020): 363-378. doi: https://doi.org/10.1016/j.jaccao.2020.08.006
Leerink JM, de Baat EC, Feijen EAM, Bellersen L, van Dalen EC, Grotenhuis HB, Kapusta L, Kok WEM, Loonen J, van der Pal HJH, Pluijm SMF, Teske AJ, Mavinkurve-Groothuis AMC, Merkx R, Kremer LCM. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: . JACC CardioOncol. 2020 Sep 15;2(3):363-378. doi: 10.1016/j.jaccao.2020.08.006. eCollection 2020 Sep. PMID: 34396245; PMCID: PMC8352294.
Copy Download .nbib Format: NLM
Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors.

Neuro-oncology advances

Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, Dessens AB, Waslander R, van den Adel TPL, Pluijm SMF, Reddingius RE, Michiels E, van den Heuvel-Eibrink MM, Hartman A.
PMID: 34988449
Neurooncol Adv. 2021 Nov 03;3(1):vdab161. doi: 10.1093/noajnl/vdab161. eCollection 2021.

BACKGROUND: Pediatric brain tumor survivors (PBTS) experience disease- and treatment-related sequelae. We aimed to investigate the occurrence of participation limitations, impairments in functioning, fatigue, and the association between patient, tumor- and treatment-related factors and these outcomes.METHODS: Children (4-18 years)...

Cite
Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, et al. Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neurooncol Adv. 2021;3(1):vdab161doi: 10.1093/noajnl/vdab161.
Verwaaijen, E. J., Catsman-Berrevoets, C. E., Maurice-Stam, H., Dessens, A. B., Waslander, R., van den Adel, T. P. L., Pluijm, S. M. F., Reddingius, R. E., Michiels, E., van den Heuvel-Eibrink, M. M., & Hartman, A. (2021). Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neuro-oncology advances, 3(1), vdab161. https://doi.org/10.1093/noajnl/vdab161
Verwaaijen, Emma J, et al. "Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors." Neuro-oncology advances vol. 3,1 (2021): vdab161. doi: https://doi.org/10.1093/noajnl/vdab161
Verwaaijen EJ, Catsman-Berrevoets CE, Maurice-Stam H, Dessens AB, Waslander R, van den Adel TPL, Pluijm SMF, Reddingius RE, Michiels E, van den Heuvel-Eibrink MM, Hartman A. Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors. Neurooncol Adv. 2021 Nov 03;3(1):vdab161. doi: 10.1093/noajnl/vdab161. eCollection 2021. PMID: 34988449; PMCID: PMC8704380.
Copy Download .nbib Format: NLM
[No title available]

Tijdschrift voor gerontologie en geriatrie

Pluijm SM, Visser M, Puts MT, Dik MG, Schalk BW, van Schoor NM, Schaap LA, Bosscher RJ, Deeg DJ.
PMID: 23203826
Tijdschr Gerontol Geriatr. 2006 Dec;37(6):283-295. doi: 10.1007/BF03074811.

No abstract available.

Cite
Pluijm SM, Visser M, Puts MT, et al. Ongezonde leefstijl in de loop van het leven: samenhang met lichamelijke achteruitgang op oudere leeftijd. . Tijdschr Gerontol Geriatr. 2006;37(6):283-295doi: 10.1007/BF03074811.
Pluijm, S. M., Visser, M., Puts, M. T., Dik, M. G., Schalk, B. W., van Schoor, N. M., Schaap, L. A., Bosscher, R. J., & Deeg, D. J. (2006). Ongezonde leefstijl in de loop van het leven: samenhang met lichamelijke achteruitgang op oudere leeftijd. . Tijdschrift voor gerontologie en geriatrie, 37(6), 283-295. https://doi.org/10.1007/BF03074811
Pluijm, S M F, et al. "Ongezonde leefstijl in de loop van het leven: samenhang met lichamelijke achteruitgang op oudere leeftijd." . Tijdschrift voor gerontologie en geriatrie vol. 37,6 (2006): 283-295. doi: https://doi.org/10.1007/BF03074811
Pluijm SM, Visser M, Puts MT, Dik MG, Schalk BW, van Schoor NM, Schaap LA, Bosscher RJ, Deeg DJ. Ongezonde leefstijl in de loop van het leven: samenhang met lichamelijke achteruitgang op oudere leeftijd. . Tijdschr Gerontol Geriatr. 2006 Dec;37(6):283-295. doi: 10.1007/BF03074811. Dutch. PMID: 23203826.
Copy Download .nbib Format: NLM
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.

Rheumatology and therapy

Gosselt HR, Verhoeven MMA, de Rotte MCFJ, Pluijm SMF, Muller IB, Jansen G, Tekstra J, Bulatović-Ćalasan M, Heil SG, Lafeber FPJG, Hazes JMW, de Jonge R.
PMID: 32926395
Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14.

INTRODUCTION: Methotrexate (MTX) constitutes the first-line therapy in rheumatoid arthritis (RA), yet approximately 30% of the patients do not benefit from MTX. Recently, we reported a prognostic multivariable prediction model for insufficient clinical response to MTX at 3 months...

Cite
Gosselt HR, Verhoeven MMA, de Rotte MCFJ, et al. Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio. Rheumatol Ther. 2020;7(4):837-850doi: 10.1007/s40744-020-00230-7.
Gosselt, H. R., Verhoeven, M. M. A., de Rotte, M. C. F. J., Pluijm, S. M. F., Muller, I. B., Jansen, G., Tekstra, J., Bulatović-Ćalasan, M., Heil, S. G., Lafeber, F. P. J. G., Hazes, J. M. W., & de Jonge, R. (2020). Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio. Rheumatology and therapy, 7(4), 837-850. https://doi.org/10.1007/s40744-020-00230-7
Gosselt, Helen R, et al. "Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio." Rheumatology and therapy vol. 7,4 (2020): 837-850. doi: https://doi.org/10.1007/s40744-020-00230-7
Gosselt HR, Verhoeven MMA, de Rotte MCFJ, Pluijm SMF, Muller IB, Jansen G, Tekstra J, Bulatović-Ćalasan M, Heil SG, Lafeber FPJG, Hazes JMW, de Jonge R. Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio. Rheumatol Ther. 2020 Dec;7(4):837-850. doi: 10.1007/s40744-020-00230-7. Epub 2020 Sep 14. PMID: 32926395; PMCID: PMC7695780.
Copy Download .nbib Format: NLM
Disability-free life expectancy: a cross-national comparison of six longitudinal studies on aging. The CLESA project.

European journal of ageing

Minicuci N, Noale M, Pluijm SMF, Zunzunegui MV, Blumstein T, Deeg DJH, Bardage C, Jylhä M.
PMID: 28794700
Eur J Ageing. 2004 Dec;1(1):37-44. doi: 10.1007/s10433-004-0002-5. Epub 2004 Nov 03.

Disability-free life expectancy (DFLE) was compared in six countries taking part in the Cross-national Determinants of Quality of Life and Health Services for the Elderly (CLESA) project. Data from six existing longitudinal studies were used: TamELSA (Tampere, Finland), CALAS...

Cite
Minicuci N, Noale M, Pluijm SMF, et al. Disability-free life expectancy: a cross-national comparison of six longitudinal studies on aging. The CLESA project. Eur J Ageing. 2004;1(1):37-44doi: 10.1007/s10433-004-0002-5.
Minicuci, N., Noale, M., Pluijm, S. M. F., Zunzunegui, M. V., Blumstein, T., Deeg, D. J. H., Bardage, C., Jylhä, M. (2004). Disability-free life expectancy: a cross-national comparison of six longitudinal studies on aging. The CLESA project. European journal of ageing, 1(1), 37-44. https://doi.org/10.1007/s10433-004-0002-5
Minicuci, N, et al. "Disability-free life expectancy: a cross-national comparison of six longitudinal studies on aging. The CLESA project." European journal of ageing vol. 1,1 (2004): 37-44. doi: https://doi.org/10.1007/s10433-004-0002-5
Minicuci N, Noale M, Pluijm SMF, Zunzunegui MV, Blumstein T, Deeg DJH, Bardage C, Jylhä M. Disability-free life expectancy: a cross-national comparison of six longitudinal studies on aging. The CLESA project. Eur J Ageing. 2004 Dec;1(1):37-44. doi: 10.1007/s10433-004-0002-5. Epub 2004 Nov 03. PMID: 28794700; PMCID: PMC5502679.
Copy Download .nbib Format: NLM
Disability and social ties: comparative findings of the CLESA study.

European journal of ageing

Zunzunegui MV, Rodriguez-Laso A, Otero A, Pluijm SMF, Nikula S, Blumstein T, Jylhä M, Minicuci N, Deeg DJH.
PMID: 28794715
Eur J Ageing. 2005 Mar;2(1):40-47. doi: 10.1007/s10433-005-0021-x. Epub 2005 Mar 04.

The associations between prevalence, incidence and recovery from activities of daily living (ADL) disability and social ties among community-dwelling persons over 65 in Finland, The Netherlands and Spain are examined. Data were harmonized in the CLESA study. The baseline...

Cite
Zunzunegui MV, Rodriguez-Laso A, Otero A, et al. Disability and social ties: comparative findings of the CLESA study. Eur J Ageing. 2005;2(1):40-47doi: 10.1007/s10433-005-0021-x.
Zunzunegui, M. V., Rodriguez-Laso, A., Otero, A., Pluijm, S. M. F., Nikula, S., Blumstein, T., Jylhä, M., Minicuci, N., Deeg, D. J. H. (2005). Disability and social ties: comparative findings of the CLESA study. European journal of ageing, 2(1), 40-47. https://doi.org/10.1007/s10433-005-0021-x
Zunzunegui, M V, et al. "Disability and social ties: comparative findings of the CLESA study." European journal of ageing vol. 2,1 (2005): 40-47. doi: https://doi.org/10.1007/s10433-005-0021-x
Zunzunegui MV, Rodriguez-Laso A, Otero A, Pluijm SMF, Nikula S, Blumstein T, Jylhä M, Minicuci N, Deeg DJH. Disability and social ties: comparative findings of the CLESA study. Eur J Ageing. 2005 Mar;2(1):40-47. doi: 10.1007/s10433-005-0021-x. Epub 2005 Mar 04. PMID: 28794715; PMCID: PMC5547668.
Copy Download .nbib Format: NLM
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Verwaaijen EJ, Ma J, de Groot-Kruseman HA, Pieters R, van der Sluis IM, van Atteveld JE, Halton J, Fernandez CV, Hartman A, de Jonge R, Lequin MH, Te Winkel ML, Alos N, Atkinson SA, Barr R, Grant RM, Hay J, Huber AM, Ho J, Jaremko J, Koujok K, Lang B, Matzinger MA, Shenouda N, Rauch F, Rodd C, van den Heuvel-Eibrink MM, Pluijm SMF, Ward LM.
PMID: 34610647
J Bone Miner Res. 2021 Dec;36(12):2290-2299. doi: 10.1002/jbmr.4442. Epub 2021 Oct 05.

Although bone fragility may already be present at diagnosis of pediatric acute lymphoblastic leukemia (ALL), routine performance of dual-energy X-ray absorptiometry (DXA) in every child is not universally feasible. The aim of this study was to develop and validate...

Cite
Verwaaijen EJ, Ma J, de Groot-Kruseman HA, et al. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. J Bone Miner Res. 2021;36(12):2290-2299doi: 10.1002/jbmr.4442.
Verwaaijen, E. J., Ma, J., de Groot-Kruseman, H. A., Pieters, R., van der Sluis, I. M., van Atteveld, J. E., Halton, J., Fernandez, C. V., Hartman, A., de Jonge, R., Lequin, M. H., Te Winkel, M. L., Alos, N., Atkinson, S. A., Barr, R., Grant, R. M., Hay, J., Huber, A. M., Ho, J., Jaremko, J., Koujok, K., Lang, B., Matzinger, M. A., Shenouda, N., Rauch, F., Rodd, C., van den Heuvel-Eibrink, M. M., Pluijm, S. M. F., Ward, L. M. (2021). A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(12), 2290-2299. https://doi.org/10.1002/jbmr.4442
Verwaaijen, Emma J, et al. "A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia." Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 36,12 (2021): 2290-2299. doi: https://doi.org/10.1002/jbmr.4442
Verwaaijen EJ, Ma J, de Groot-Kruseman HA, Pieters R, van der Sluis IM, van Atteveld JE, Halton J, Fernandez CV, Hartman A, de Jonge R, Lequin MH, Te Winkel ML, Alos N, Atkinson SA, Barr R, Grant RM, Hay J, Huber AM, Ho J, Jaremko J, Koujok K, Lang B, Matzinger MA, Shenouda N, Rauch F, Rodd C, van den Heuvel-Eibrink MM, Pluijm SMF, Ward LM. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia. J Bone Miner Res. 2021 Dec;36(12):2290-2299. doi: 10.1002/jbmr.4442. Epub 2021 Oct 05. PMID: 34610647.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries